Journal Club

HomeMembersAssemblies and SectionsAssembliesAllergy, Immunology and InflammationJournal Club ▶ Preexisting Type 2 Immune Activation Protects against the Development of Sepsis and Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality
Preexisting Type 2 Immune Activation Protects against the Development of Sepsis and Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality

Webinar date: December 20th, 2017

Presenters:

Paulette Krishack, PhD
Section of Pulmonary and Critical Care Medicine
University of Chicago

Joe Zein, MD
Respiratory Institute
Cleveland Clinic

Discussant Panelists:

Philip Verhoef, MD, PhD
Assistant Professor of Medicine and Pediatrics Section of Pulmonary and Critical Care Medicine
University of Chicago

Richard S. Hotchkiss, MD
Professor of Anesthesiology, Medicine, and Surgery
Washington University School of Medicine

Jeffrey A. Gold, MD
Professor of Medicine
Oregon Health & Sciences University

Moderator:

Catherine Bonham, MD
Instructor, Section of Pulmonary and Critical Care Medicine
University of Chicago

Last Reviewed: January 2018